Structural requirements of quassinoids for the inhibition of cell transformation.
D001358:Avian Sarcoma Viruses / Q000187:drug effects / Q000378:metabolism*; D002472:Cell Transformation, Viral / Q000187:drug effects*; D004247:DNA / Q000096:biosynthesis; D004261:DNA Replication / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005900:Glaucarubin / Q000031:analogs & derivatives; D007783:Lactones / Q000494:pharmacology*; D007930:Leucine / Q000378:metabolism; D010616:Phenanthrenes / Q000494:pharmacology*; D014176:Protein Biosynthesis; D036702:Quassins; D012313:RNA / Q000096:biosynthesis; D013329:Structure-Activity Relationship
D007783:Lactones; D010616:Phenanthrenes; D036702:Quassins; C015235:glaucarubinone; C024973:simarolide; C024967:glaucarubolone; C024966:chaparrinone; C024965:bruceine B; C024964:bruceine A; C024970:simalikalactone D; D012313:RNA; C024968:castelanone; C024972:soulameanone; C024969:soularubinone; D004247:DNA; D005900:Glaucarubin; D007930:Leucine